Scopus BioPharma Inc (SCPS)

Etorro trading 970x250
Scopus BioPharma Inc (SCPS) Logo

About Scopus BioPharma Inc

Scopus BioPharma Inc. develops therapeutics drugs targeting the endocannabinoid system. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December, 2017. The company was incorporated in 2017 and is based in New York, New York. Address: 420 Lexington Avenue, New York, NY, United States, 10170

Scopus BioPharma Inc News and around…

Latest news about Scopus BioPharma Inc (SCPS) common stock and company :

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
18 May, 2022 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) shares moved upwards by 17.3% to $0.4 during Wednesday's pre-market session. ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
10 May, 2022 FinancialContent

Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their ...

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
05 May, 2022 Yahoo! Finance

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharmaNEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced the appointment of Raphael (“Rafi”) Hofstein, Ph.D. to its Board of Directors (“Board”). Joshua R. Lamstein, Chairman of Scopus BioPharma, stated, “We are thrilled Dr. Hofstein is rejoining our

Stocks That Hit 52-Week Lows On Tuesday
26 Apr, 2022 FinancialContent

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms ...

Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit
23 Mar, 2022 Yahoo! Finance

Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to Immuno-Oncology NEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced that Alan Horsager, Ph.D., President and Chief Executive Officer of Duet BioTherapeutics, will

75 Biggest Movers From Yesterday
22 Mar, 2022 FinancialContent

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received ...

12 Health Care Stocks Moving In Monday's Intraday Session
21 Mar, 2022 FinancialContent

Gainers Scopus BioPharma (NASDAQ:SCPS) shares rose 72.1% to $1.1 during Monday's regular session. Trading volume for Scopus ...

64 Biggest Movers From Yesterday
18 Mar, 2022 FinancialContent

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership ...

12 Health Care Stocks Moving In Thursday's After-Market Session
03 Mar, 2022 FinancialContent

Gainers Puma Biotechnology (NASDAQ:PBYI) shares moved upwards by 12.0% to $2.61 during Thursday's after-market session. The company's ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
18 Feb, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're starting off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Interested in Crypto? Read This First...

60 Biggest Movers From Yesterday
18 Feb, 2022 FinancialContent

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the ...

56 Biggest Movers From Yesterday
17 Feb, 2022 FinancialContent

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated ...

Stocks That Hit 52-Week Lows On Monday
14 Feb, 2022 FinancialContent

During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 ...

Stocks That Hit 52-Week Lows On Wednesday
19 Jan, 2022 FinancialContent

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Jan, 2022 FinancialContent

Gainers Biomerica (NASDAQ:BMRA) stock increased by 10.2% to $4.95 during Wednesday's after-market session. The market value of their ...

Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
10 Jan, 2022 Yahoo! Finance

Overwhelming Majority of Shares Voted by Unaffiliated Stockholderswere in Favor of Scopus' Director Nominees Lasters’ Ownership Position and Annual Meeting Results are being Challenged in Court Company Believes Ultimate Outcome of Annual Meeting Will Depend on Results of Pending Cases NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS) (“Scopus” or the “Company”) today announced that it has filed an amendment to the Current Report on Form 8-K that was filed by the Co

DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS
06 Jan, 2022 Yahoo! Finance

Dr. Morris C. Laster ("Dr. Laster"), who, together with other proxy participants, beneficially owns 6,006,000 shares of common stock, par value $0.001, of Scopus BioPharma Inc. (Nasdaq: SCPS) ("Scopus" or the "Company"), announced today that stockholders of the Company have elected Dr. Laster's two director nominees, Mordechai Saar Hacham and Joshua Levine to the Company's Board of Directors at the Company's 2021 Annual Meeting of Stockholders (the "Annual Meeting").

Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Company
17 Dec, 2021 Yahoo! Finance

Latest Legal Claims by Laster Actually Call into Question his Stock Ownership Company Urges Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today issued a second letter to its stockholders in connection with the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) that will be reconvened on Monday, December 20, 2021 at 11:30 a.m., Eastern time. The record date f

Peek Under The Hood: IWC Has 43% Upside
09 Dec, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $205.15 per unit.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
08 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We've reached the halfway point of the week and there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card
07 Dec, 2021 Yahoo! Finance

Company’s Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to Create an Industry-Leading Portfolio of Bi-Functional Cancer Targeting Molecules Recently Raised $9.75 Million in Non-Dilutive Financing; Dilution was Fully Absorbed Through the Executive Committee’s Contribution Back to the Company of Warrants to Purchase Six Million Shares Financing Provides the Cash Runway to Reach Value Creation Milestones Ex

Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual Meeting
06 Dec, 2021 Yahoo! Finance

Dr. Morris C. Laster ("Dr. Laster"), who, together with the other proxy participants, beneficially owns 6,006,000 shares of common stock, par value $0.001 in Scopus BioPharma Inc. (Nasdaq: SCPS) ("Scopus" or the "Company"), issued an open letter to Scopus stockholders today in connection with the Company's upcoming Annual Meeting. The open letter highlights the following key points and encourages stockholders to vote for Dr. Laster's director nominees:

Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market
22 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced it has entered into securities purchase agreements with certain institutional investors in connection with a private placement priced at-the-market under Nasdaq rules of 3,000,000 shares of common stock, series A additional investment options (the “Series A

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders
08 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced that, on November 5, 2021, its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) was adjourned to 11:30 a.m., Eastern time, on Monday, December 20, 2021, without any business being conducted. The adjourned meeting will be held by means of remote communication and can be accessed via the following URL: http://www.cesonlineservices.com/scps21_vm. The adjournment date is pursuant to an unders

We Did The Math IWC Can Go To $208
04 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $207.52 per unit.

12 Health Care Stocks Moving In Monday's After-Market Session
25 Oct, 2021 FinancialContent

Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 10.73% to $208.6 during Monday's after-market session. The market value ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Oct, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Scopus BioPharma to Present at the LD Micro Main Event
05 Oct, 2021 Yahoo! Finance

Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology Presentation to include a discussion of preclinical data released at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced it wi

18 Stocks Moving in Monday's Pre-Market Session
04 Oct, 2021 FinancialContent

Gainers CohBar, Inc. (NASDAQ: CWBR) rose 22.8% to $1.13 in pre-market trading after dropping over 4% on Friday. Farmmi, Inc.. ...

Scopus BioPharma Inc (SCPS) is a NASDAQ Common Stock listed in , ,

970x250